Working hours:

We accept orders 24/7

0
My order
Add items to wish list
Add items to comparison

Visoluten 60

SKU 7020340
In stock
Description

PRODUCTS DESCRIPTION

The efficiency of “Visoluten” was confirmed during clinical studies. It is effective for the complex restoration of vision organ function in case of diseases of various genesis. This includes degenerative-dystrophic diseases of the retina, and post-traumatic dystrophy of the cornea. It is also used for the prevention of fatigue and irritation of eyes during long work in front of a computer and manages the influence of various environment factors. It is also effective when aging to optimize the visual function.

Recommended:

  • In case of retina angiopathy;
  • In case of detachment and degeneration of the retina;
  • In case of elevated stress and eye fatigue;
  • In case of glaucoma or cataract;
  • In case of accommodation spasm;
  • During long work in front of the computer;
  • When driving a car at night-time;
  • When using decorative cosmetics;
  • When swimming in a pool with chlorinated water.

Ingredients:

microcrystalline cellulose (bulking agent); hydroxypropyl methylcellulose (capsule shell), water, carrageenan (thickener), potassium acetate (acidity regulator); peptide complex A-11, containing amino acids (arginine, glutamic acid, aspartic acid, isoleucine); calcium salts of fatty acids (anti-caking agent).

The recommended daily dose, or 2 or 4 capsules, contains 20 mg or 40 mg of peptide complex А-11.

Recommendations for use:

adults by 1 or 2 capsules 2 times a day during meals. Duration of use is 1 month. The use can be repeated after 3-6 months.

€95
€127
Compare
Sign in
to add this item to wishlist
%
Sign in to see your personal discount
A new review or comment
Rate this item
Send
Up

We care about your privacy

This website uses cookies for marketing and statistical purposes and for a secure and optimal site experience. You can change this in your browser settings. Click on the «Accept cookies» button to consent using cookies. You can read more on the User agreement page.